Ligand Pharmaceuticals Inc Reports 57% Increase In Q3 Earnings

(RTTNews) - Ligand Pharmaceuticals Inc (LGND) reported earnings for its third quarter that climbed from last year.

The company said its bottom line came in at $11.98 million, or $0.56 per share. This was up from $7.62 million, or $0.36 per share, in last year's third quarter.

Analysts had expected the company to earn $0.42 per share, according figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company said revenue for the quarter rose 18.2% to $17.70 million. This was up from $14.97 million last year.

Ligand Pharmaceuticals Inc earnings at a glance:

-Earnings (Q3): $11.98 Mln. vs. $7.62 Mln. last year. -Earnings Growth (Y-o-Y): 57.2% -EPS (Q3): $0.56 vs. $0.36 last year. -EPS Growth (Y-o-Y): 55.6% -Analysts Estimate: $0.42 -Revenue (Q3): $17.70 Mln vs. $14.97 Mln last year. -Revenue Change (Y-o-Y): 18.2%

-Guidance: Next quarter EPS guidance: $0.63 - $0.66 Next quarter revenue guidance: $24.3 - $25.3 Mln Full year EPS guidance: $3.34 - $3.37 Full year revenue guidance: $75 - $76 Mln